(Updated - May 10, 2024 4:58 AM EDT)

Barclays analyst Peter Lawson upgraded Relay Therapeutics (NASDAQ: RLAY) from Equalweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE